Parallax Volatility Advisers’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-96,000
Closed -$3.4M 3264
2020
Q2
$3.4M Buy
+96,000
New +$2.81M ﹤0.01% 1242
2020
Q1
Sell
-180,000
Closed -$3.81M 2883
2019
Q4
$3.81M Buy
180,000
+30,000
+20% +$529K ﹤0.01% 1005
2019
Q3
$1.99M Sell
150,000
-100,000
-40% -$1.47M ﹤0.01% 1143
2019
Q2
$3.47M Buy
250,000
+100,000
+67% +$1.5M ﹤0.01% 854
2019
Q1
$2.88M Buy
+150,000
New +$2.42M ﹤0.01% 868
2018
Q1
Sell
-158,700
Closed -$2.56M 4927
2017
Q4
$2.56M Buy
158,700
+109,000
+219% +$1.29M ﹤0.01% 835
2017
Q3
$695K Hold
49,700
﹤0.01% 1165
2017
Q2
$439K Hold
49,700
﹤0.01% 1263
2017
Q1
$322K Buy
49,700
+24,700
+99% +$125K ﹤0.01% 1728
2016
Q4
$92K Buy
+25,000
New +$74K ﹤0.01% 2239
2016
Q2
Sell
-47,000
Closed -$118K 3857
2016
Q1
$118K Buy
+47,000
New +$106K ﹤0.01% 1927
2015
Q4
Sell
-2,600
Closed -$4K 4220
2015
Q3
$4K Hold
2,600
﹤0.01% 2684
2015
Q2
$11K Buy
+2,600
New +$10.6K ﹤0.01% 3138

Other funds holding IMMU

Parallax Volatility Advisers's IMMU Position: Q3 2020 in Review

Parallax Volatility Advisers sold out of Immunomedics Inc (IMMU) in Q3 2020, closing a stake of 23 shares — an estimated $1K sold.

Parallax Volatility Advisers first reported a position in IMMU in Q2 2017 and held it in 10 quarters. The position peaked at $3.64M in Q2 2018. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.

  • Parallax Volatility Advisers reported no remaining Immunomedics Inc position as of Q3 2020 after selling out during the quarter.
  • Parallax Volatility Advisers sold 23 Immunomedics Inc shares in Q3 2020, an estimated $1K.
  • Parallax Volatility Advisers first reported a position in Immunomedics Inc in Q2 2017 and held it in 10 quarters.
  • Parallax Volatility Advisers's Immunomedics Inc position peaked at $3.64M in Q2 2018.
  • 408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.

Based on Parallax Volatility Advisers's 13F filing for Q3 2020, filed 13 Nov 2020.